Source: Okayama University (JAPAN), Public Relations Division
For immediate release: 9 November 2022
Okayama University research: COVID-19 mRNA vaccines and fever: A possible new link

(Okayama, 9 November) In a report published in the Journal of Epidemiology, researchers from Okayama University investigate the link between the incidence of fever and antibody levels after the third dose of a COVID-19 mRNA vaccine.

mRNA vaccines for COVID-19 generate adverse reactions such as fever and fatigue which are considered normal and are transient in nature. However, there has been a growing fear of taking the mRNA-1273 vaccine prevalent in Japan, due to these unpleasant effects. Now, there is sparse clinical evidence about the relationship between this incidence of fever and antibody counts, especially after the third dose of the vaccine. Professor YORIFUJI Takashi and Assistant Professor MATSUMOTO Naomi colleagues from Okayama University have investigated this link over a period of time and recently published their findings in a short report in the Journal of Epidemiology.

mRNA vaccines mimic the surface structure of SARS-CoV-2 in the body. Immune cells then treat these as invading pathogens and produce antibodies against them. Thus, antibody counts can be used as a quantitative outcome of the immune system’s response to a vaccine. For their study, the researchers recruited 49 university staff and students as subjects. Only participants who had not previously suffered from COVID-19 (to the best of their knowledge) were selected.

All subjects were surveyed for adverse reactions a week after they received the third mRNA-1273 vaccine dose. Simultaneously, antibody levels of all subjects were measured just before receiving the vaccine, 3 days after, ~1 week after, and finally 1 month after the dose. Using statistical modeling, correlations between the incidence of fever and antibody levels at various time points was stipulated. To account for factors contributing to the onset of fever post-vaccination, the team also looked at sex, age differences, a history of allergy, and the use of antipyretics (fever-reducing drugs) amongst the participants.

The subjects were then classified into a “fever” or “nonfever” group based on the survey results. It was found that the fever group was more likely to be younger (20 to 49 years-old) and had a past history of allergies. Next, antibody levels at different time points in the two groups were analyzed. At 1 week post vaccination, the fever group had substantially higher antibody counts than the nonfever group. However, at 1 month post vaccination there seemed to be no correlation between the incidence of fever and high antibody levels.

This is the first study to highlight associations between the induction of fever and antibody levels at various time points after the third dose of the mRNA-1273 vaccine. “Antibody titers after mRNA-1273 vaccination may be faster in the group with post-vaccination fever, but the difference may not be significant 1 month post-vaccination,” concludes the team. The researchers also suggest that while these contradictory observations may not have significant clinical relevance, a study with a larger sample size might provide better insights.

Background
COVID-19 mRNA vaccines and antibodies: mRNA vaccines come with a set of instructions to produce viral proteins in our body. mRNA-1273 enters our cells and produces the spike protein— a protein found on the surface of SARS-CoV-2. Our immune cells then recognize this protein as a foreign object and produce antibodies against it, which will build over time. These are known as antibody titers. If a vaccinated individual is infected with SARS-CoV-2 in the future, the immune cells will immediately recognize the spike protein and ramp up production of these antibodies to fight off the infection.

Due to the extensive involvement of the immune system, mRNA vaccines tend to produce symptoms such as fatigue, fever, headaches, and body aches. There is also a theory that chemicals known as lipids, which protect and deliver the mRNA molecules, might aggravate the immune response. Since the onset of fever and an increase in antibody titers are both a function of vaccine-induced immune reactions, a link between the two might have important clinical significance.

Reference
Naomi Matsumoto, Tomoka Kadowaki, Rumi Matsuo, Ayako Sasaki, Chikara Miyaji, Chigusa Higuchi, Masanori Nakayama, Yasue Sakurada, Hideharu Hagiya, Soshi Takao, Fumio Otsuka, Takashi Yorifuji. Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine. Journal of Epidemiology, 2022 Aug 27.
DOI：https://doi.org/10.2188/jea.JE20220210
https://www.jstage.jst.go.jp/article/jea/advpub/0/advpub_JE20220210/_article

Correspondence to
Professor YORIFUJI Takashi, M.D., Ph.D.
Department of Epidemiology, Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences, Okayama University, 2-5-1
Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
E-mail: yorichan@md.okayama-u.ac.jp
https://www.unit-gp.jp/eisei/wp/?cat=77

Further information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations Division
E-mail: www-adm(a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Website: //www.okayama-u.ac.jp/index_e.html
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
We love OKAYAMA UNIVERSITY: https://www.youtube.com/watch?v=7cXlttQIk3E
Okayama University Image Movie（2020）
https://www.youtube.com/watch?v=BKRoF0tffmA
Okayama University supports the Sustainable Development Goals: https://sdgs.okayama-u.ac.jp/en/

Okayama University Medical Research Updates （OU-MRU）
The whole volume : OU-MRU (1- )
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testing
Vol.2：Ensuring a cool recovery from cardiac arrest
Vol.3：Organ regeneration research leaps forward
Vol.4：Cardiac mechanosensitive integrator
Vol.5：Cell injections get to the heart of congenital defects
Vol.6：Fourth key molecule identified in bone development
Vol.7：Anticancer virus solution provides an alternative to surgery
Vol.8：Light-responsive dye stimulates sight in genetically blind patients
Vol.9：Diabetes drug helps towards immunity against cancer
Vol.10：Enzyme-inhibitors treat drug-resistant epilepsy
Vol.11：Compound-protein combination shows promise for arthritis treatment
Vol.12：Molecular features of the circadian clock system in fruit flies
Vol.13：Peptide directs artificial tissue growth
Vol.14：Simplified boron compound may treat brain tumours
Vol.15：Metamaterial absorbers for infrared inspection technologies
Vol.16：Epigenetics research traces how crickets restore lost limbs
Vol.17：Cell research shows pathway for suppressing hepatitis B virus
Vol.18：Therapeutic protein targets liver disease
Vol.19：Study links signalling protein to osteoarthritis
Vol.20：Lack of enzyme promotes fatty liver disease in thin patients
Vol.21：Combined gene transduction and light therapy targets gastric cancer
Vol.22：Medical supportive device for hemodialysis catheter puncture
Vol.23：Development of low cost oral inactivated vaccines for dysentery
Vol.24：Sticky molecules to tackle obesity and diabetes
Vol.25：Self-administered aroma foot massage may reduce symptoms of anxiety
Vol.26：Protein for preventing heart failure
Vol.27：Keeping cells in shape to fight sepsis
Vol.28：Viral-based therapy for bone cancer
Vol.29：Photoreactive compound allows protein synthesis control with light
Vol.30：Cancer stem cells’ role in tumor growth revealed
Vol.31：Prevention of RNA virus replication
Vol.32：Enzyme target for slowing bladder cancer invasion
Vol.33：Attacking tumors from the inside
Vol.34：Novel mouse model for studying pancreatic cancer
Vol.35：Potential cause of Lafora disease revealed
Vol.36：Overloading of protein localization triggers cellular defects
Vol.37：Protein dosage compensation mechanism unravelled
Vol.38：Bioengineered tooth restoration in a large mammal
Vol.39：Successful test of retinal prosthesis implanted in rats
Vol.40：Antibodies prolong seizure latency in epileptic mice
Vol.41：Inorganic biomaterials for soft-tissue adhesion
Vol.42：Potential drug for treating chronic pain with few side effects
Vol.43：Potential origin of cancer-associated cells revealed
Vol.44：Protection from plant extracts
Vol.45：Link between biological-clock disturbance and brain dysfunction uncovered
Vol.46：New method for suppressing lung cancer oncogene
Vol.47：Candidate genes for eye misalignment identified
Vol.48：Nanotechnology-based approach to cancer virotherapy
Vol.49：Cell membrane as material for bone formation
Vol.50：Iron removal as a potential cancer therapy
Vol.51：Potential of 3D nanoenvironments for experimental cancer
Vol.52：A protein found on the surface of cells plays an integral role in tumor growth and sustenance
Vol.53：Successful implantation and testing of retinal prosthesis in monkey eyes with retinal degeneration
Vol.54：Measuring ion concentration in solutions for clinical and environmental research
Vol.55：Diabetic kidney disease: new biomarkers improve the prediction of the renal prognosis
Vol.56：New device for assisting accurate hemodialysis catheter placement
Vol.57：Possible link between excess chewing muscle activity and dental disease
Vol.58：Insights into mechanisms governing the resistance to the anti-cancer medication cetuximab
Vol.59：Role of commensal flora in periodontal immune response investigated
Vol.60：Role of commensal microbiota in bone remodeling
Vol.61：Mechanical stress affects normal bone development
Vol.62：3D tissue model offers insights into treating pancreatic cancer
Vol.63：Promising biomarker for vascular disease relapse revealed
Vol.64：Inflammation in the brain enhances the side-effects of hypnotic medication
Vol.65：Game changer: How do bacteria play Tag ?
Vol.66：Is too much protein a bad thing?
Vol.67：Technology to rapidly detect cancer markers for cancer diagnosis
Vol.68：Improving the diagnosis of pancreatic cancer
Vol.69：Early gastric cancer endoscopic diagnosis system using artificial intelligence
Vol.70：Prosthetics for Retinal Stimulation
Vol.71：The nervous system can contribute to breast cancer progression
Vol.72：Synthetic compound provides fast screening for potential drugs
Vol.73：Primary intraocular lymphoma does not always spread to the central nervous system
Vol.74：Rising from the ashes—dead brain cells can be regenerated after traumatic injury
Vol.75：More than just daily supplements — herbal medicines can treat stomach disorders
Vol.76：The molecular pathogenesis of muscular dystrophy-associated cardiomyopathy
Vol.77：Green leafy vegetables contain a compound which can fight cancer cells
Vol.78：Disrupting blood supply to tumors as a new strategy to treat oral cancer
Vol.79：Novel blood-based markers to detect Alzheimer’s disease
Vol.80：A novel 3D cell culture model sheds light on the mechanisms driving fibrosis in pancreatic cancer
Vol.81：Innovative method for determining carcinogenicity of chemicals using iPS cells
Vol.82：Making memories — the workings of a neuron revealed
Vol.83：Skipping a beat — a novel method to study heart attacks
Vol.84：Friend to Foe—When Harmless Bacteria Turn Toxic
Vol.85：Promising imaging method for the early detection of dental caries
Vol.86：Plates and belts — a toolkit to prevent accidental falls during invasive vascular proceduresa
Vol.87：Therapeutic potential of stem cells for treating neurodegenerative disease
Vol.88：Nanotechnology for making cancer drugs more accessible to the brain
Vol.89：Studying Parkinson’s disease with face-recognition software
Vol.90：High levels of television exposure affect visual acuity in children
Vol.91：Meeting high demand: Increasing the efficiency of antiviral drug production in bacteria
Vol.92：Numerical modelling to assist the development of a retinal prosthesis
Vol.93：Repurposing cancer drugs: An innovative therapeutic strategy to fight bone cancer
Vol.94：A berry vine found in Asia proves useful in combating lung cancer
Vol.95：A new avenue for detecting cancer in the blood
Vol.96：Automated cell image analysis
Vol.97：Artificial intelligence helps to determine cancer invasion
Vol.98：Okayama University launches clinical trials of a jawbone regeneration therapy using human BMP-2 transgenic protein derived from Escherichia coli.
Vol.99：A rapid flow process that can convert droplets into multilayer polymeric microcapsules
Vol.100：Understanding insect leg regeneration
Vol.101：Oral tumor progression mechanism identified
Vol.102：Controlled cell death by irradiation with light
Vol.103：High-quality growth
Vol.104：The determinants of persistent and severe COVID-19 revealed
Vol.105：The dynamics of skin regeneration revealed
Vol.106：The skin electrically modelled